APA (7th ed.) Citation

Y, S., YC, P., Y, X., W, T., E, S., MZ, D., . . . DJ, S. (2026). A human cardiomyocyte screen identifies optimized lipid nanoparticles for in vivo cardiac gene editing. Proceedings of the National Academy of Sciences of the United States of America, 123(21), e2528477123. https://doi.org/10.1073/pnas.2528477123

Chicago Style (17th ed.) Citation

Y, Sun, et al. "A Human Cardiomyocyte Screen Identifies Optimized Lipid Nanoparticles for in Vivo Cardiac Gene Editing." Proceedings of the National Academy of Sciences of the United States of America 123, no. 21 (2026): e2528477123. https://doi.org/10.1073/pnas.2528477123.

MLA (9th ed.) Citation

Y, Sun, et al. "A Human Cardiomyocyte Screen Identifies Optimized Lipid Nanoparticles for in Vivo Cardiac Gene Editing." Proceedings of the National Academy of Sciences of the United States of America, vol. 123, no. 21, 2026, p. e2528477123, https://doi.org/10.1073/pnas.2528477123.